PhDr. Karel Hejduk
Researcher, Institute of Biostatistics and Analyses
correspondence Address:
Kamenice 753/5, 625 00 Brno
office: 354
Poštovská 68/3
602 00 Brno
phone: | +420 549 49 7246 |
---|---|
e‑mail: |
Total number of publications: 202
2017
-
Epidemiologie, hospitalizační léčba a migrace IBD pacientů za specializovanou péčí v České Republice
Gastroenterologie a hepatologie, year: 2017, volume: 71, edition: 6
-
Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
Year: 2017, type: Conference abstract
-
CHARAKTERISTIKY PACIENTŮ S NSCLC A AKTIVAČNÍMI MUTACEMI EGFR LÉČENÝCH INHIBITORY TYROZINKINÁZY PO STANOVENÍ DIAGNÓZY - REÁLNÁ DATA Z ČESKÉ REPUBLIKY
Year: 2017, type: Conference abstract
-
Jak používáme v České republice inhibitory tyrozinkinázy (TKI) po stanovení diagnózy u pacientů s NSCLC?
Year: 2017, type: Conference abstract
-
Léčba pokročilého nemalobuněčného karcinomu plic (NSCLC) v ČR v roce 2017 (aktuální stav, výhled do budoucna)
Year: 2017, type: Conference abstract
-
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed
Neoplasma, year: 2017, volume: 64, edition: 4, DOI
-
Prospective Assessment of Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Categories and Chronic Obstructive Pulmonary Disease (COPD) Phenotypes: Evolution During Two Years
Year: 2017, type: Conference abstract
-
Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, year: 2017, volume: 18, edition: 12, DOI
-
Registr TULUNG
Year: 2017, type: Conference abstract
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI